Educational Objectives:

•    Differentiate the mechanisms of action and titration schedules for GLP-1 RAs and dual GIP/GLP-1 RAs in the management of obesity

•    Identify patient candidates for anti-obesity medications by integrating current clinical guidelines with patient-specific cardiometabolic comorbidities

•    Examine the scope of pharmacist involvement in developing evidence-based mitigation strategies to manage common medication adverse effects and risk factors for suboptimal medication-taking behaviors

•    Explore practical workflows to resolve systemic, provider, and patient-level barriers to obesity care in daily practice

Overview:

This session equips pharmacists with the clinical and operational strategies needed to optimize obesity management, covering practical concerns from the unique mechanisms of action and titration schedules of GLP-1 and dual GIP/GLP-1 receptor agonists to navigating guidelines, comorbidities, and adverse effects. Through an interactive, case-based workshop, participants will collaborate with peers to evaluate practical workflows that address systemic, provider, and patient-level barriers to long-term medication use in daily practice.

Activity Disclaimer